Medicinal mushrooms have a long history of use in Asia and are quickly gaining acceptance elsewhere for a variety of health challenges, including cancer and enhancing immune function. Thus far research concerning their use for multiple sclerosis in particular has been limited, but at least two medicinal mushrooms have shown some promise.
Ads by Google
Optic neuritis is a presenting condition in 20 percent of people who have multiple sclerosis. In fact, optic neuritis occurs in half of all individuals with MS at some time during their lives, so it’s important to understand this vision challenge.
The relationship between seizures, optic neuritis, and multiple sclerosis may seem difficult to fathom, but the results of a new study shed some light on the subject. It appears that the common antiseizure drug called phenytoin has the ability to help prevent the development of acute optic neuritis, an eye condition frequently seen in people who have multiple sclerosis.
Two topical skin drugs that are already approved for dermatology purposes could be beneficial for people with multiple sclerosis. The finding comes from a research team at Case Western Reserve.
High doses of biotin, which is also known as vitamin H, were associated with improvements in disability among patients with progressive multiple sclerosis. The results of this latest study, which follows on the heels of another research endeavor concerning biotin for multiple sclerosis, will be presented at the American Academy of Neurology annual meeting on April 24, 2015.
The first Canadian clinical trial to explore mesenchymal stem cell therapy for multiple sclerosis is now underway with the help of a $4.2 million grant. This groundbreaking effort is under the direction of Mark S. Freedman, MD, of the University of Ottawa and The Ottawa Hospital.
A new meta-analysis and review of statins for multiple sclerosis has just been published, and it seemed like a good opportunity to take a look at what scientists say about statins for MS. It also would be enlightening to hear from people with multiple sclerosis concerning their experiences and opinions about using these drugs.
About five years ago I interviewed a young woman (let’s call her Rose) with multiple sclerosis who was managing the disease with natural remedies. One of those remedies was curcumin, a compound present in the curry spice called turmeric.
A new study showed that a drug used to treat high blood pressure prevented the loss of myelin in multiple sclerosis animal models. The blood pressure drug, called guanabenz (Wytensin), also reduced clinical symptoms of the disease.
It appears that a drug currently on the market to treat overactive bladder may help restore myelin in patients with multiple sclerosis. More specifically, the drug promotes remyelination, a natural process that fails to progress properly in people who have MS.
Individuals with multiple sclerosis want to know what’s going on behind closed doors concerning drug research for this disease. A new study shows that MS patients want full disclosure concerning the financial relationship between the doctors and the drug companies in pharmaceutical industry-sponsored clinical trials (ISCTs) before they will agree to participate in such research.
The role of coffee in multiple sclerosis can be viewed from two perspectives: its ability to prevent or decrease risk of the disease and its impact on individuals who already have MS. Since a new study has addressed the former scenario, it seems like a good time to look at the effect of coffee on both sides of the question.
Individuals with multiple sclerosis who live within a reasonable radius of the University of Illinois at Urbana-Champaign may be eligible for one of two studies about falling. Even though falling is a major concern for people with multiple sclerosis, few studies have targeted fall prevention, especially involving home exercise.
A new study suggests that coffee consumption can reduce the risk of multiple sclerosis.
Researchers at Johns Hopkins University found that women with multiple sclerosis have a lower intake of five nutrients when compared with their healthy peers. These five antioxidant and anti-inflammatory nutrients may play an important role in the disease, so what should women do?
Individuals with multiple sclerosis have the power to advance the research and discovery efforts of scientists and ultimately improve MS treatment. An opportunity to wield that power is possible through the iConquerMS(TM) campaign, which is a new endeavor by the nonprofit organization, Accelerated Cure Project for Multiple Sclerosis (ACPMS).
Imagine breaking out into uncontrollable laughter or crying bouts for no apparent reason and in inappropriate settings. For about 10 percent of individuals who live with multiple sclerosis, this possibility is all too familiar.
Treatment with a form of stem cell transplantation in individuals with relapsing-remitting multiple sclerosis has demonstrated improvements in neurological disability, quality of life, and cognitive function. The new study, which appears in a recent issue of the Journal of the American Medical Association, did not show similar positive results for individuals with secondary progressive MS.
Problems with balance and gait are two issues that face individuals who live with multiple sclerosis. Now a new pilot study is hoping to see how they might improve these challenges with the use of vibrating insoles.
Investigators have just released the interim results of a five-year study of high-dose immunosuppressive therapy (HDIT) and hematopoietic stem cell therapy in 24 individuals with multiple sclerosis. After three years, most of the participants showed improvements in neurological function and sustained remission of active relapsing-remitting MS (RRMS).
Studies in Sweden and Germany indicate that underweight women with multiple sclerosis who take the MS drug Gilenya (fingolimod) seem to be at increased risk for lymphopenia. The drug also poses a risk for patients who have low lymphocyte levels before they start drug treatment.
Playing video games can be more than fun; it can be a therapeutic experience for people who live with multiple sclerosis. Several studies have explored the value of video games for managing multiple sclerosis symptoms, and more research is in the works. What’s the scoop?
Vitamin B12 deficiency is a problem frequently associated with the elderly, a form of anemia, Crohn’s disease, and vegans. Another group that should be conscious of the value of vitamin B12 are those who live with multiple sclerosis.
When clinicians are considering a diagnosis of multiple sclerosis, one of the other diseases that may be on their radar is neuromyelitis optica. That’s because neuromyelitis optica and multiple sclerosis share some critical characteristics.
Some people insist there is a relationship between multiple sclerosis and cow’s milk while others say such an association is nonsense. The following information may or may not change your mind, regardless of which side of the aisle you are on. However, it is information you may want to consider in your management of MS.
Researchers have made a new discovery about myelin that could have a significant impact on how multiple sclerosis is viewed and treated. The finding concerns cells called oligodendrocytes, which have a crucial role in nervous system functioning.